DELAWARE
|
33-0824714
|
|
(State
of jurisdiction of Incorporation)
|
(I.R.S.
Employer Identification No.)
|
|
|
|
|
8885
REHCO RD. SAN DIEGO, CA
|
92121
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
2005
|
High
|
Low
|
First
Quarter
|
|
|
Second
Quarter
|
|
|
Third
Quarter
|
3.55
|
0.12
|
Fourth
Quarter
|
3.25
|
2.75
|
2006
|
|
|
First
Quarter
|
3.00
|
1.5
|
Second
Quarter Third Quarter
|
3.00
|
1.26
|
Fourth
Quarter
|
3.19
|
1.51
|
|
2.00
|
0.49
|
Laboratory
information systems
|
|
$
|
30,000
|
|
Laminar
flow hoods (2 ea) 4ft
|
|
$
|
10,000
|
|
Sepax
Cell Separation Device
|
|
$
|
50,000
|
|
Blood
processing equipment
|
|
$
|
80,000
|
|
Bar
code labeling equipment
|
|
$
|
3,000
|
|
Tube
heat sealers (2 ea)
|
|
$
|
4,000
|
|
Bench
top centrifuges (2) refrigerated
|
|
$
|
12,000
|
|
Cell
Therapy Software
|
|
$
|
30,000
|
|
Cryo
Tracking Software
|
|
$
|
28,000
|
|
Cryo
Tracking Equipment
|
|
$
|
45,000
|
|
Hematology
analyzer
|
|
$
|
15,000
|
|
Flow
Cytometer
|
|
$
|
150,000
|
|
BacTec
Microbiology equipment
|
|
$
|
20,000
|
|
Small
equipment (lab set-up)
|
|
$
|
10,000
|
|
Microscope
|
|
$
|
5,000
|
|
CO2
Incubator
|
|
$
|
4,000
|
|
Lab
benches
|
|
$
|
30,000
|
|
Supplies
/ reagents*
|
|
$
|
100,000
|
|
Total
|
|
$
|
626,000
|
|
Computer
system / Lab & offices
|
|
$
|
100,000
|
|
Medical
Software
|
|
$
|
45,000
|
|
Misc
equipment
|
|
$
|
30,000
|
|
Phone
system
|
|
$
|
30,000
|
|
Back-up
generator
|
|
$
|
50,000
|
|
Security
system
|
|
$
|
20,000
|
|
Total
|
|
$
|
275,000
|
|
Director of
Labs
|
|
$
|
120,000
|
|
Director of
Quality & Assurance
|
|
$
|
75,000
|
|
Adm.
Director
|
|
$
|
75,000
|
|
Dir.
Of Engineering / Production
|
|
$
|
85,000
|
|
Lab
Tech
|
|
$
|
65,000
|
|
Lab
Tech
|
|
$
|
65,000
|
|
Customer
Service Representative.
|
|
$
|
45,000
|
|
Director
of Market & Sales
|
|
$
|
100,000
|
|
Facility
Manager / Receiving & Shipping
|
|
$
|
60,000
|
|
Support
Staff
|
|
$
|
50,000
|
|
Total
|
|
$
|
740,000
|
|
Bio-Matrix
Scientific Group Inc.
|
|
(A
Development Stage Company)
|
|
Consolidated
|
|
Balance
Sheet
|
|
As
of
September
30, 2006
|
||||
ASSETS
|
||||
CURRENT
ASSETS
|
||||
Cash
|
$ |
22,641
|
||
Pre-paid
Expenses
|
20,207
|
|||
Total
Current Assets
|
42,848
|
|||
PROPERTY
& EQUIPMENT
|
340,557
|
|||
Intangible
Assets/Technology
|
-
|
|||
Total
Other Assets
|
29,127
|
|||
TOTAL
ASSETS
|
$ |
412,532
|
||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||
CURRENT
LIABILITIES
|
||||
Accounts
payable
|
$ |
91079
|
||
Loans
from former parent
|
1195196
|
|||
Due
To/ From New Parent
|
0
|
|||
Accrued
Payroll Taxes
|
4,983
|
|||
Accrued
Expenses
|
1,368
|
|||
Accrued
payroll taxes
|
11,477
|
|||
-
|
||||
-
|
||||
Total
Current Liabilities
|
1,453,055
|
|||
-
|
||||
LONG-TERM
LIABILITIES
|
-
|
|||
TOTAL
LIABILITIES
|
1,453,055
|
|||
-
|
||||
STOCKHOLDERS'
EQUITY
|
-
|
|||
Preferred
Stock ($.0001 par value authorized
|
||||
20,000,000 shares authorized; none issued and outstanding)
|
||||
Common
Stock, ($.0001 par value authorized
|
-
|
|||
80,000,000 shares authorized; 13,385,000
|
||||
shares issued and outstanding as of September 30, 2006
|
1,339
|
|||
Additional
paid-in Capital
|
1,379,332
|
|||
Deficit
accumulated during the development stage
|
(2,421,194 | ) | ||
Total
Stockholders' Equity (Deficit)
|
$ | (1,040,523 | ) |
Bio-Matrix
Scientific Group, Inc.
|
|
(A
Development Stage company)
|
|
Statements
of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
Inception
|
|
|||
|
|
|
|
|
|
|
|
(August
2,
2005)
|
|
|||
|
|
9
Months
Ended
|
|
|
12
Months
Ended
|
|
|
through
|
|
|||
|
|
September
30,
|
|
|
December
31,
|
|
|
September
30,
|
|
|||
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
REVENUES
|
|
|
|
|
|
|
|
|
|
|||
Sales
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
Revenues
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COSTS
AND EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
Research
and Development
|
|
|
75,453
|
|
|
|
135,387
|
|
|
|
210,840
|
|
General
and administrative
|
|
|
1,138,364
|
|
|
|
186,202
|
|
|
|
1,324,566
|
|
Depreciation
and amortization
|
|
|
742
|
|
|
|
140
|
|
|
|
882
|
|
Consulting
and professional fees
|
|
|
801,635
|
|
|
|
46,054
|
|
|
|
847,689
|
|
Impairment
of Intangibles
|
|
|
34,688
|
|
|
|
|
|
|
|
34,688
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
Costs and Expenses
|
|
|
2,050,882
|
|
|
|
367,783
|
|
|
|
2,418,665
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING
LOSS
|
|
|
(2,050,882
|
)
|
|
|
(367,783
|
)
|
|
|
(2,418,665
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER
INCOME & (EXPENSES)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
Expense
|
|
|
(2,367
|
)
|
|
|
(162
|
)
|
|
|
(2,529
|
)
|
Interest
Income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Other
income
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
Other Income & (Expenses)
|
|
|
(2,367
|
)
|
|
|
(162
|
)
|
|
|
(2,529
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET
INCOME (LOSS)
|
|
$
|
(2,053,249
|
)
|
|
$
|
(367,945
|
)
|
|
$
|
(2,421,194
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC
AND DILUTED EARNINGS (LOSS) PER SHARE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC
AND DILUTED EARNINGS (LOSS) PER SHARE
|
|
$
|
(0.19
|
)
|
|
$
|
(14.72
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WEIGHTED
AVERAGE NUMBER OF
|
|
|
|
|
|
|
|
|
|
|
|
|
COMMON SHARES OUTSTANDING
|
|
|
10,960,440
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bio-Matrix
Scientific Group, Inc.
|
|
(A
Development Stage Company)
|
|
Consolidated
Statement of Changes in Stockholders' Equity
|
|
From
August 2, 2005 through September 30, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
|
|||||
|
|
Common
|
|
|
Paid-in
|
|
|
Retained
|
|
|
|
|
||||||||
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Earnings
|
|
|
Total
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Shares
issued to Parent
|
|
|
25,000
|
|
|
|
35,921
|
|
|
|
|
|
|
|
|
|
35,921
|
|
||
Net
Loss August 2, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
through
September 30, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,000
|
)
|
|
|
(1,000
|
)
|
|
Balance
September 30, 2005
|
|
|
25,000
|
|
|
|
35,921
|
|
|
|
-
|
|
|
|
(1,000
|
)
|
|
|
34,921
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Loss October 1, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
through
December 31, 2005
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(366,945
|
)
|
|
|
(366,945
|
)
|
Balance
December 31, 2005
|
|
|
25,000
|
|
|
|
35,921
|
|
|
|
-
|
|
|
|
(367,945
|
)
|
|
|
(332,024
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recapitalization
|
|
|
9,975,000
|
|
|
|
(34,921
|
)
|
|
|
34,921
|
|
|
|
|
|
|
|
-
|
|
Stock
issued July 3, 2006 Tasco Merger
|
|
|
2,780,000
|
|
|
|
278
|
|
|
|
(278
|
)
|
|
|
|
|
|
|
-
|
|
Stock
issued for services
|
|
|
305,000
|
|
|
|
31
|
|
|
|
759,719
|
|
|
|
|
|
|
|
759,750
|
|
Stock
issued for Compensation
|
|
|
300,000
|
|
|
|
30
|
|
|
|
584,970
|
|
|
|
|
|
|
|
585,000
|
|
Net
Loss January 1, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
through September 30, 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,053,249
|
)
|
|
|
(2,053,249
|
)
|
Balance
September 30, 2006
|
|
|
13,385,000
|
|
|
|
1,339
|
|
|
|
1,379,332
|
|
|
|
(2,421,194
|
)
|
|
|
(1,040,523
|
)
|
Bio-Matrix
Scientific Group, Inc
|
|
(A
Development Stage Company)
|
|
Consolidated
Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
August
2, 2005
|
|
|||
|
|
|
|
|
|
|
|
(inception)
|
|
|||
|
|
Year
Ended
|
|
|
Year
Ended
|
|
|
through
|
|
|||
|
|
September
30,
|
|
|
December
31,
|
|
|
September
30,
|
|
|||
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Net
(loss)
|
|
$
|
(2,053,249
|
)
|
|
$
|
(367,945
|
)
|
|
$
|
(2,421,194
|
)
|
Adjustments
to reconcile net loss to net cash (used in) provided
|
|
|
|
|
|
|
|
|
|
|
|
|
by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
expense
|
|
|
742
|
|
|
|
140
|
|
|
|
882
|
|
Stock
issued for compensation
|
|
|
585,000
|
|
|
|
-
|
|
|
|
585,000
|
|
Stock
issued for services
|
|
|
759,750
|
|
|
|
-
|
|
|
|
759,750
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
(Increase)
decrease in prepaid expenses
|
|
|
(15,074
|
)
|
|
|
(5,133
|
)
|
|
|
(20,207
|
)
|
(Increase)
decrease in organizational costs
|
|
|
|
|
|
|
-
|
|
|
|
|
|
Increase
(Decrease) in Accounts Payable
|
|
|
67,878
|
|
|
|
23,201
|
|
|
|
91,079
|
|
Increase
(Decrease) in Accrued Expenses
|
|
|
15,799
|
|
|
|
2,029
|
|
|
|
17,828
|
|
(Increase)
Decrease in Deposits
|
|
|
-
|
|
|
|
(29,127
|
)
|
|
|
(29,127
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Cash Provided by (Used in) Operating
Activities
|
|
|
(639,154
|
)
|
|
|
(376,835
|
)
|
|
|
(1,015,989
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH
FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases
of fixed assets
|
|
|
(237,874
|
)
|
|
|
(103,565
|
)
|
|
|
(341,439
|
)
|
Purchases
of Intangible assets
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Cash Provided by (Used in) Investing
Activities
|
|
|
(237,874
|
)
|
|
|
(103,565
|
)
|
|
|
(341,439
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CASH
FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common
stock issued for cash
|
|
|
-
|
|
|
|
|
|
|
|
|
|
Additional
paid-in Capital
|
|
|
-
|
|
|
|
35,921
|
|
|
|
35,921
|
|
Principal
borrowings on notes
|
|
|
148,952
|
|
|
|
-
|
|
|
|
148,952
|
|
Net
borrowings from related parties
|
|
|
750,450
|
|
|
|
444,746
|
|
|
|
1,195,196
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Cash Provided by (Used in) Financing
Activities
|
|
|
899,402
|
|
|
|
480,667
|
|
|
|
1,380,069
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Increase (Decrease) in Cash
|
|
|
22,374
|
|
|
|
267
|
|
|
|
22,641
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
at Beginning of Year
|
|
|
267
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
at End of Year
|
|
$
|
22,641
|
|
|
$
|
-
|
|
|
|
(22,641
|
)
|
|
|
|
|
|
|
|
64,022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Cash
Flow Disclosures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
paid during period for interest
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
paid during period for taxes
|
|
$
|
800
|
|
|
$
|
800
|
|
|
$
|
800
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|||
Acquisition
cost:
|
|
|
|
|
|
Production
Equipment
|
US
|
|
$
|
93,315
|
|
Production
Clean room
|
|
|
|
56,917
|
|
Leasehold
improvement
|
|
|
|
185,482
|
|
Office
equipment
|
|
|
|
3,057
|
|
Computer
|
|
|
|
2,668
|
|
Subtotal
|
|
|
|
341,439
|
|
Less
accumulated depreciation
|
|
|
|
882
|
|
Total
|
US
|
|
$
|
340,557
|
|
As of September , 2006 | ||||
|
|
|
|
|
Deferred
tax assets:
|
|
|
|
|
Net
operating tax carry forwards
|
|
$
|
853,117
|
|
Other
|
|
|
-0-
|
|
Gross
deferred tax assets
|
|
|
853,117
|
|
Valuation
allowance
|
|
|
(853,117
|
)
|
|
|
|
|
|
Net
deferred tax assets
|
|
$
|
-0-
|
|
2006
|
$ |
227,739
|
|||
2007
|
$ |
234,562
|
|||
2008
|
$ |
241,611
|
|||
2009
|
$ |
248,864
|
|||
2010
|
$ |
234,377
|
|
|
Number
of
|
|
|
|
|
Shares
|
|
|
Twelve
months ended September 30, 2006:
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
605,000
|
*
|
|
|
|
|
|
Remaining
shares available for issuance under the Plan as of September 30,
2006
|
|
|
895,000
|
|
23-Aug-07
|
$ |
23,683.00
|
|||
24-Aug-07
|
$ |
16,667.21
|
|||
30-Aug-07
|
$ |
7,077.59
|
|||
30-Aug-07
|
$ |
26,122.00
|
|||
5-Sep-07
|
$ |
787.50
|
|||
7-Sep-07
|
$ |
7,269.87
|
|||
12-Sep-07
|
$ |
1,900.00
|
|||
13-Sep-07
|
$ |
12,085.72
|
|||
13-Sep-07
|
$ |
6,128.93
|
|||
21-Sep-07
|
$ |
2,200.00
|
|||
28-Sep-07
|
$ |
6,075.50
|
|||
28-Sep-07
|
$ |
28,754.53
|
|||
5-Oct-07
|
$ |
23,751.63
|
|||
11-Oct-07
|
$ |
14,000.00
|
|||
11-Oct-07
|
$ |
6,120.57
|
|||
12-Oct-07
|
$ |
982.12
|
|||
18-Oct-07
|
$ |
7,186.15
|
|||
8-Nov-07
|
$ |
52,051.90
|
|||
9-Nov-07
|
$ |
3,900.00
|
Name
|
|
Age
|
|
Position
|
|
David
R. Koos
|
|
49
|
|
Chairman
of the Board of Directors, President, CEO, Secretary, and Acting
CFO
|
|
Brian
Pockett
|
|
53
|
|
Vice
President and COO, Director
|
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Chairman,
President, CEO and Acting CFO
|
Bio-Matrix
Scientific Group,
Inc.
|
June
14, 2006 (Chairman) to Present
June
19, 2006 (President, CEO and Acting CFO)
June
19, 2006(Secretary) to Present
|
Chairman,
Chief Executive Officer, Secretary &Acting Chief Financial
Officer
|
Frezer
Inc.
|
May
2, 2005 to Present
|
Chairman,
Chief Executive Officer, Secretary &Acting Chief Financial
Officer
|
BMXP
Holdings, Inc.
BMSG
|
December
6, 2004 to Present
|
Managing
Director & President
|
Cell
Source Research Inc.
|
December
5, 2001 to Present
|
Managing
Director & President
|
Venture
Bridge Inc.
|
November
21, 2001 to Present
|
Member
of the Board of Directors, Chief Financial Officer &
Secretary
|
Cell
Bio-Systems Inc.
(New
York)
|
July
17, 2003 to December 1, 2003
|
Registered
Representative
|
Amerivet
Securities Inc.*
|
March
31, 2004 to Present
(Previously
employed: November, 2000 to
May,2002)
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Vice
President, COO and Director
|
Bio-Matrix
Scientific Group, Inc.
|
June
19, 2006 (Vice President and COO) to Present
June
14, 2006 (Director) to Present
|
Managing
Director & Chief Operating Officer
|
Frezer
Inc.
|
May
2, 2005 to Present
|
Managing
Director & Chief Operating Officer
|
BMXP
Holdings, Inc.
BMSG
|
December
6, 2004 to Present
|
Business
Development Consultant
|
Cell
Bio-Systems Inc.
(New
York)
|
April
1, 2003 to November 30, 2004
|
Sales
& Marketing Consultant
|
North
County Times
|
July
1, 2002 to March 15, 2003
|
Independent
Magazine Contractor
|
DaVinci
|
January
1, 2000 to June 30, 2002
|
Independent
Magazine Contractor
|
Digital
Diner
|
January
1, 2000 to June 30, 2002
|
Independent
Magazine Contractor
|
Shock
Waves
|
January
1, 2000 to June 30, 2002
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Chief
Scientific Advisor
|
Bio-Matrix
Scientific Group, Inc.
|
August
9, 2006 to present
|
President
|
Frezer
Inc., San Diego , CA
|
May
2, 2005 to present
|
President
|
BMXP
Holdings, Inc.. San Diego, CA
|
March,
2005 to present
|
Consultant
in Biotechnology
|
Self
employed, Tarpon Springs FL
|
July,
2004 to March, 2005
|
Laboratory
and Scientific Director
|
Cryo-Cell
International Inc, Clearwater, FL
|
April,
1999 to June, 2004
|
SUMMARY
COMPENSATION TABLE
|
|
|
|||||||
Name
and principal position
|
Year
|
Salary($)
|
Bonus($)
|
Stock
Awards($)
(a)
|
Option
Awards($)
|
Non-Equity
Incentive
Plan
Compensation
($)
|
Nonqualified
Deferred
Compensation
Earnings
($)
|
All
Other
Compensation
($)
|
Total
($)
|
Dr.
David Koos
Chairman,
CEO and President
|
October
1, 2005
to
September 30,
2006
|
0
|
0
|
$292,500
|
0
|
0
|
0
|
0
|
$292,500
|
Mr.
Brian Pockett
Vice
President,
COO
and Director
|
October
1, 2005
to
September 30,
2006
|
0
|
0
|
$292,500
|
|
|
0
|
0
|
$292,500
|
Title
of Class
|
Name
and Address of Beneficial Owner
|
Amount
and Nature of Beneficial Owner
|
Percent
of Class
|
Common
|
David
R. Koos (a)
C/o
Bio-Matrix Scientific Group, Inc
8885
REHCO RD.SAN DIEGO CA92121
|
12,640,738
|
55
|
Common
|
Brian
Pockett
(a)
C/o
Bio-Matrix Scientific Group, Inc
8885
REHCO RD.SAN DIEGO CA92121
|
11,639,530
|
50.2
|
Common
|
BMXP
Holdings Shareholder Business Trust
|
11,462,570
|
49.5
|
Common
|
All
Officers and Directors
As
a
Group(a)
|
12,817,698
|
55
|
EXHIBIT
NUMBER
|
|
DESCRIPTION
|
|
|
|
|
|
31.1**
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
32.1**
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT
|
|
31.2**
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
32.2**
|
|
CERTIFICATION
BY CFO PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT
|
|
31.3*
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
31.4*
|
|
CERTIFICATION
BY CFO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
31.5***
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
31.6***
|
|
CERTIFICATION
BY CFO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
31.7
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
31.8
|
|
CERTIFICATION
BY CFO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
|
|
Period
beginning
Oct
1, 2005
and
ending September
30,
2006
|
|
|
|
|
|
|
|
Audit
Fees
|
|
$
|
5,800
|
|
Audit
Related Fees
|
|
|
4,670
|
|
Tax
Fees
|
|
|
0
|
|
All
Other Fees
|
|
|
75
|
|
|
|
|
|
|
|
|
$
|
10,545
|
|
|
|
|
|
|
|
|
Period
beginning
Oct.
1, 2005
and
ending September
30,
2006
|
|
|
|
|
|
|
|
Audit
Fees
|
|
$
|
0
|
|
Audit
Related Fees
|
|
|
2,500
|
|
Tax
Fees
|
|
|
0
|
|
All
Other Fees
|
|
|
0
|
|
|
|
|
|
|
|
|
$
|
2,500
|
|
|
By:
|
/s/ David
R. Koos
|
|
|
|
David
R. Koos
|
|
|
|
Chairman,
CEO and President
|
|